Patients should avoid food allergens when taking the drug, according to the FDA. Finally, the biosimilar agent can be used for patients with chronic spontaneous urticaria — ongoing unexplained ...

February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart ...

At the same time, 90% of U.S. prescriptions are either generics or biosimilars saving the U.S. healthcare system $445 billion in 2023 alone. Despite these achievements, there are important reforms ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one manufacturer of striking a “surreptitious” deal that could arguably ...

A panelist discusses how managing biosimilars requires close collaboration between payers and health systems to optimize patient care and cost savings, while sharing insights about program ...

Feb. 20, 2025 -- The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people with diabetes, including children and adults. The product, called Merilog ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first financial year as an independent company. After completing its spin-off from ...

Two biosimilars to Humira (adalimumab ... employees, affiliates, agents, advisors, or representatives liable in any respect for the provision of this communication, the information contained ...